Dr David Chang
Honorary Conjoint Fellow
The Sir Peter MacCallum Department of Oncology
18 Scholarly works
1 Projects
HIGHLIGHTS
2025
Journal article
Impact of the R.E.N.A.L. complexity score on outcomes of stereotactic ablative body radiotherapy for primary renal cell carcinoma
DOI: 10.1111/bju.168432025
Journal article
A population-based analyses of the evolving management of cN1M0 prostate cancer in the PSMA-PET era
DOI: 10.1002/bco2.700592025
Journal article
PSMA-Guided Metastasis-Directed Therapy for Oligometastatic Renal Cell Carcinoma: The Proof-of-Concept PEDESTAL Study
DOI: 10.2967/jnumed.124.2686392024
Research grants (other domestic)
Stereotactic Ablative Body Radiotherapy (SABR) for 4 Gynaecologic Metastases
2024
Journal article
Automated lattice radiation therapy treatment planning personalised to tumour size and shape
DOI: 10.1016/j.ejmp.2024.1044902024
Journal article
Partially Ablative Body Radiotherapy (PABR): A novel approach for palliative radiotherapy of locally advanced bulky unresectable sarcomas
DOI: 10.1016/j.radonc.2024.1102752024
Journal article
Partially Ablative Body Radiotherapy (PABR): A novel approach for palliative radiotherapy of locally advanced bulky unresectable sarcomas
DOI: 10.1016/j.radonc.2024.110185
RECENT SCHOLARLY WORKS
2024
Conference Proceedings
Partially Ablative Body Radiotherapy (PABR): A novel approach for unresectable sarcomas
DOI: 10.1016/s0167-8140(24)02421-62024
Journal article
SABR for oligometastatic renal cell carcinoma.
DOI: 10.1016/j.ctro.2024.1007392024
Journal article
Low rate of severe-end-stage kidney disease after SABR for localised primary kidney cancer
DOI: 10.1186/s13014-024-02413-w2024
Journal article
EGFR Targeting of Liposomal Doxorubicin Improves Recognition and Suppression of Non-Small Cell Lung Cancer
DOI: 10.2147/IJN.S450534